An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.
A joint conference by the National Association of Specialty Pharmacy and the Association of Managed Care Pharmacy attracted hundreds of leaders from across the specialty pharmacy industry.
BioPlus Specialty Pharmacy will notify physicians within two hours whether a patient has been accepted for treatment, the company said.
Teva Pharmaceutical Industries has launched a generic opioid medication for treating pain, the company said.
GlaxoSmithKline has started a late-stage clinical trial of a drug in patients with an inflammatory disease that affects the blood vessels.
Swiss drug maker Covis Pharma will buy U.S. rights to five drugs from Sanofi, Covis said.
Novartis is promoting the multiple sclerosis drug Gilenya to young people with a new ad campaign in several national magazine's and websites, according to published reports.
A committee of Florida's state Senate has passed a bill that could limit the use of biosimilars in the state.
The Food and Drug Administration has given preliminary approval to a drug made by Aurobindo Pharma for treating HIV infection, the drug maker said.
Washington-based accrediting organization URAC has accredited pharmacy benefit manager Catamaran Corp.'s specialty pharmacy brand, Catamaran said.